September 17, 2018 5:57pm

The NASDAQ (-1.43%) and IBB (-1.32%) while the VIX jumps +13.34%

Some or many sector worries may never be realized yet; it’s time for cyclical equities to be vulnerable

 

After every dramatic decline, there happens a rebound

 

Pre-open indications: 3 HIT and 0 MISS

 

Who is defining the metrics for individual investors and which broker, trader, fund or I-Bank is keeping you notified of the sector and market fluctuations?

RMi’s daily report may say little or a lot and its final judgement may be inconclusive; yet it serves as insurance that all indications are being examined and evaluated.

Henry’omics:

The title says it all

... as sentiment is in the toilet, thank you algorithms - may your "rules" be broken!!

From the pre-open newsletter: “volume has been turned down. What will illuminate equity’s value if momentum is light? A trade wars materialize over markets.”

I also stated, “As the month of September grinds … and to an end along with the quarter – Q3; are we warned that the same grinding effect will be perpetrated on sector equities?”

I didn’t ignore last week’s choppiness … with all the “skeptics” talking trash about the market – it’s scaring the markets and investors!

 

Daily analytics and metrics:

  • The Dow dropped -92.56 points or -0.35% to 26,062.12
  • The S&P closed down -16.18 points or -0.56% to 2,888.80
  • The NASDAQ closed down -114.25 or -1.43% to 7,895.79

 

The advance/decline line scenario of 45 covered companies:   

  • The open was negative with an A/DL of 15/8 and 2 flats;
  • The mid-day was negative with an A/DL of 14/30 and 1 flat;
  • The close was negative with an A/DL of 12/31 and 2 flats;

 

Pre-open indications: 3 HITs

  • CRISPR Therapeutics (CRSP) closed down -$5.04 - hit;
  • Editas Medicine (EDIT) closed down -$0.54– hit;
  • Intellia Therapeutics (NTLA) closed down -$1.20– hit;

 

Of the 45 companies covered on Monday; 31 downside equities finished in a range of -0.74% (BOLD) to -13.36% (RGNX) while 12 upside equity oscillated from +0.29% (STML) to +6.41% (AGTC) with 2  flat closes (AST and CUR).

 

Five (5) key metrics:  

… The greatest volume to the downside:  VSTM, SGMO, RGNX, BMRN and CRSP

… Upside volume was weighted to:  IONS, MDXG, VCEL, HSGX and BTX

… Leadership ($) to the downside:  RGNX (-$10.85), BLUE (-$8.90), CRSP (-$5.04), SLDB (-$4.67) and RARE (-$4.33)

… Best moves ($) to the upside:  IONS (+$2.19), CLLS (+$0.59), OSIR (+$0.29), AGTC (+$0.25) and VCEL (+$0.10)

 

The iShares NASDAQ Biotechnology (IBB) closed:

  • Monday was down -1.32%
  • Friday was down 0.51%
  • Thursday was up +0.74%
  • Wednesday was up +0.05%
  • Tuesday was down -0.42%
  • Last Monday was up +0.17%

 

September sessions:

Monday’s closed NEGATIVE with 31 decliners, 12 advancers and 2 flats 

Friday’s closed POSITIVE with 19 decliners, 23 advancer and 3 flats 

Thursday’s closed NEGATIVE with 22 decliners, 20 advancer and 3 flats 

Wednesday’s closed POSITIVE with 20 decliners, 25 advancer and 0 flats 

Tuesday’s closed POSITIVE with 20 decliners, 23 advancer and 2 flats 

Monday’s closed NEGATIVE with 28 decliners, 17 advancer and 2 flats 

Friday’s closed POSITIVE with 15 decliners, 23 advancer and 7 flats 

Thursday’s closed NEGATIVE with 39 decliners, 1 advancer and 5 flats 

Wednesday’s closed NEGATIVE with 30 decliners, 12 advancers and 3 flats 

Tuesday’s (9/4) closed NEGATIVE with 22 decliners, 19 advancers and 4 flats  

 

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.